The Consumer Product Safety Commission (CPSC) has released the final supplemental guidance for its Chronic Hazard Guidelines.

This critical release incorporates new methods for assessing chronic health risks from consumer products under the Federal Hazardous Substances Act. The supplemental guidance introduces an advanced benchmark dose methodology for estimating acceptable daily intakes and cancer risks. An updated approach for analyzing uncertainty and variability in risk assessments introduces a probabilistic consideration of population-level exposures and risks.  

Other agencies like EPA have already adopted such approaches into their risk assessment guidance, but this is the first time they will be incorporated into the CPSC guidelines, which had not been updated since 1992. These guidance updates are designed to assist companies in meeting their regulatory obligations and advancing consumer product safety standards through scientifically backed methods.  

Whether you are a manufacturer looking to comply with the latest regulations or a product safety expert who wants to keep current with best practices, this updated guidance will benefit your assessments by providing clearer frameworks and broader approaches for determining risks at various exposure levels and confirming the safety of consumer products. 

See the full guidance to ensure your practices align with the latest science: https://www.federalregister.gov/documents/2024/04/23/2024-08604/notice-of-availability-supplemental-guidance-for-cpsc-chronic-hazard-guidelines#print